{"schema_version":"1","generated_at":"2026-10-28T17:41:27.112Z","data_as_of":null,"url":"https://www.findmykol.com/kol/mary-riwes","json_url":"https://www.findmykol.com/kol/mary-riwes/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"mary-riwes","name":"Mary Riwes","credential":"DO","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Michigan","institution_url":"https://www.findmykol.com/institution/university-of-michigan","city":"Ann Arbor","state":"MI","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1750548434","orcid":"0000-0001-5764-0410","openalex":"A5035640745"},"summary":"Mary Riwes is an Oncology physician affiliated with University of Michigan. OpenAlex indexes 68 publications with 1,038 citations (h-index 17); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":68,"cited_by_count":1038,"h_index":17,"latest_activity_year":2026,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06784336","title":"Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"University of Michigan Rogel Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT06784336","trial_url":"https://www.findmykol.com/trial/NCT06784336"},{"nct":"NCT02763033","title":"Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"University of Michigan Rogel Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT02763033","trial_url":"https://www.findmykol.com/trial/NCT02763033"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"National Marrow Donor Program","program_year":2025,"amount_usd":1717.01,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1750548434"},{"payer":"National Marrow Donor Program","program_year":2024,"amount_usd":1201,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1750548434"},{"payer":"National Marrow Donor Program","program_year":2023,"amount_usd":238.18,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1750548434"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1750548434","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":40.8,"classes_total":2,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":25.4,"drugs":[{"name":"Jakafi","share_pct":100}],"max_beneficiaries":null},{"class":"Interleukin-17A Antagonist","setting":"prescribed","share_pct":15.5,"drugs":[{"name":"Cosentyx Sensoready Pen","share_pct":100}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":36.6,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":36.6,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":null}]},{"area":"Sensory organs","share_pct":22.5,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":22.5,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2026,"last":2026},"rows_total":1,"shown":1,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"UG1HL069330","title":"BMT Core- University of Michigan Core Clinical Consortium for the BMT Clinical Trials Network (BMT CTN)","fiscal_year":2026,"amount_usd":"223829","organization":"UNIVERSITY OF MICHIGAN AT ANN ARBOR","source_url":"https://reporter.nih.gov/quickSearch/UG1HL069330"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Atrial Fibrillation After Stem Cell Transplantation","year":2026,"journal":"JACC CardioOncology","source_url":"https://doi.org/10.1016/j.jaccao.2026.01.002","status":"verified"},{"title":"Impact of Non-Compliance with NIH Consensus Guidelines for PFT Performance in Allogeneic Hematopoietic Cell Transplant Recipients.","year":2026,"journal":"Biology of Blood and Marrow Transplantation","source_url":"https://doi.org/10.1016/j.jtct.2025.12.666","status":"verified"},{"title":"PD-1 inhibition for relapse after allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndrome","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2024015200","status":"verified"},{"title":"Throwing the microbiome out with the bathwater","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025016205","status":"verified"},{"title":"Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin’s lymphoma","year":2024,"journal":"Frontiers in Immunology","source_url":"https://doi.org/10.3389/fimmu.2024.1403145","status":"verified"}],"source":"works"},"contact":{"address_1":"1500 E MEDICAL CENTER DR","city":"Ann Arbor","state":"MI","zip":"481095000","phone":"734-936-4000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1750548434","source":"identity"},"similar":[{"name":"Max Wicha","slug":"max-wicha","institution":"University of Michigan","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/max-wicha","json_url":"https://www.findmykol.com/kol/max-wicha/profile.json"},{"name":"Dinesh Khanna","slug":"dinesh-khanna","institution":"University of Michigan","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/dinesh-khanna","json_url":"https://www.findmykol.com/kol/dinesh-khanna/profile.json"},{"name":"Eva Feldman","slug":"eva-feldman","institution":"University of Michigan","specialty":"Neurology","url":"https://www.findmykol.com/kol/eva-feldman","json_url":"https://www.findmykol.com/kol/eva-feldman/profile.json"},{"name":"Matthias Kretzler","slug":"matthias-kretzler","institution":"University of Michigan","specialty":"Nephrology","url":"https://www.findmykol.com/kol/matthias-kretzler","json_url":"https://www.findmykol.com/kol/matthias-kretzler/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-12-02","provider_certified":"2020-12-02","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}